These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10668404)

  • 21. Melatonin receptor signaling: finding the path through the dark.
    Masana MI; Dubocovich ML
    Sci STKE; 2001 Nov; 2001(107):pe39. PubMed ID: 11698691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins.
    Brydon L; Roka F; Petit L; de Coppet P; Tissot M; Barrett P; Morgan PJ; Nanoff C; Strosberg AD; Jockers R
    Mol Endocrinol; 1999 Dec; 13(12):2025-38. PubMed ID: 10598579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can melatonin regulate the expression of prohormone convertase 1 and 2 genes via monomeric and dimeric forms of RZR/ROR nuclear receptor, and can melatonin influence the processes of embryogenesis or carcinogenesis by disturbing the proportion of cAMP and cGMP concentrations? Theoretic model of controlled apoptosis.
    Cieśla W
    Med Hypotheses; 2001 Feb; 56(2):181-93. PubMed ID: 11425285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Structure and function of melatonin receptors].
    Jockers R; Petit L; Brydon L; de Coppet P; Strosberg AD
    C R Seances Soc Biol Fil; 1998; 192(4):659-67. PubMed ID: 9842470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenesis of human Mel1a melatonin receptor expressed in yeast reveals domains important for receptor function.
    Kokkola T; Watson MA; White J; Dowell S; Foord SM; Laitinen JT
    Biochem Biophys Res Commun; 1998 Aug; 249(2):531-6. PubMed ID: 9712731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.
    Wallez V; Durieux-Poissonnier S; Chavatte P; Boutin JA; Audinot V; Nicolas JP; Bennejean C; Delagrange P; Renard P; Lesieur D
    J Med Chem; 2002 Jun; 45(13):2788-800. PubMed ID: 12061881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decoding photoperiodic time and melatonin in mammals: what can we learn from the pars tuberalis?
    Hazlerigg DG; Morgan PJ; Messager S
    J Biol Rhythms; 2001 Aug; 16(4):326-35. PubMed ID: 11506378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An updated phylogenetic analysis of vertebrate melatonin receptor sequences: reflection on the melatonin receptor nomenclature by the Nomenclature Subcommittee of the International Union of Pharmacology.
    Shiu SY; Pang SF
    Biol Signals Recept; 1998; 7(4):244-8. PubMed ID: 9730584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
    Zlotos DP; Jockers R; Cecon E; Rivara S; Witt-Enderby PA
    J Med Chem; 2014 Apr; 57(8):3161-85. PubMed ID: 24228714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of melatonin 1a receptor signaling and trafficking by asparagine-124.
    Nelson CS; Ikeda M; Gompf HS; Robinson ML; Fuchs NK; Yoshioka T; Neve KA; Allen CN
    Mol Endocrinol; 2001 Aug; 15(8):1306-17. PubMed ID: 11463855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin receptor subtype MT2 (Mel 1b) and not mt1 (Mel 1a) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity.
    Drazen DL; Nelson RJ
    Neuroendocrinology; 2001 Sep; 74(3):178-84. PubMed ID: 11528219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand.
    Wiesenberg I; Missbach M; Kahlen JP; Schräder M; Carlberg C
    Nucleic Acids Res; 1995 Feb; 23(3):327-33. PubMed ID: 7885826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of potent N1-substituted indole melatonin receptor agonists.
    Tsotinis A; Eleutheriades A; Hough K; Sugden D
    Chem Commun (Camb); 2003 Feb; (3):382-3. PubMed ID: 12613623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The high affinity melatonin binding site probed with conformationally restricted ligands--II. Homology modeling of the receptor.
    Grol CJ; Jansen JM
    Bioorg Med Chem; 1996 Aug; 4(8):1333-9. PubMed ID: 8879555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin receptors: are there multiple subtypes?
    Dubocovich ML
    Trends Pharmacol Sci; 1995 Feb; 16(2):50-6. PubMed ID: 7762083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Important amino acids for the function of the human MT1 melatonin receptor.
    Kokkola T; Foord SM; Watson MA; Vakkuri O; Laitinen JT
    Biochem Pharmacol; 2003 May; 65(9):1463-71. PubMed ID: 12732358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigational selective melatoninergic ligands for receptor subtype MT2.
    Wan N; Zhang FF; Ju J; Liu DZ; Zhou SY; Zhang BL
    Mini Rev Med Chem; 2013 Aug; 13(10):1462-74. PubMed ID: 23815579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin, its receptors, and relationships with biological rhythm disorders.
    Delagrange P; Guardiola-Lemaitre B
    Clin Neuropharmacol; 1997 Dec; 20(6):482-510. PubMed ID: 9403224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the human Mel 1a melatonin receptor using anti-receptor antibodies.
    Brydon L; Barrett P; Morgan PJ; Strosberg AD; Jockers R
    Adv Exp Med Biol; 1999; 460():215-20. PubMed ID: 10810516
    [No Abstract]   [Full Text] [Related]  

  • 40. Melatonin and its physiological and therapeutic properties.
    Nowak JZ; Zawilska JB
    Pharm World Sci; 1998 Feb; 20(1):18-27. PubMed ID: 9536467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.